Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-643,425
Closed -$7.16M 2308
2023
Q1
$7.16M Sell
643,425
-584,800
-48% -$5.65M 0.02% 612
2022
Q4
$12.3M Buy
1,228,225
+711,970
+138% +$6.42M 0.03% 478
2022
Q3
$6.16M Buy
516,255
+200
+0% +$4.31K 0.02% 621
2022
Q2
$16.4M Buy
516,055
+25,400
+5% +$653K 0.04% 409
2022
Q1
$14.2M Buy
490,655
+43,100
+10% +$1.53M 0.03% 497
2021
Q4
$22.5M Buy
447,555
+56,855
+15% +$2.56M 0.05% 384
2021
Q3
$14M Buy
390,700
+69,500
+22% +$2.76M 0.03% 482
2021
Q2
$14.3M Buy
321,200
+194,700
+154% +$6.64M 0.03% 497
2021
Q1
$4.6M Buy
126,500
+5,500
+5% +$229K 0.01% 741
2020
Q4
$5.17M Buy
121,000
+44,200
+58% +$1.62M 0.01% 769
2020
Q3
$1.54M Buy
+76,800
New +$1.5M ﹤0.01% 1202

Other funds holding XPEV

Canada Life's XPEV Position: Q2 2023 in Review

Canada Life sold out of XPeng (XPEV) in Q2 2023, closing a stake of 643,425 shares — an estimated $7.16M sold.

Canada Life first reported a position in XPEV in Q3 2020 and held it in 11 quarters. The position peaked at $22.5M in Q4 2021. 201 funds tracked by Wall St. Rank hold XPEV as of Q2 2023.

  • Canada Life reported no remaining XPeng position as of Q2 2023 after selling out during the quarter.
  • Canada Life sold 643,425 XPeng shares in Q2 2023, an estimated $7.16M.
  • Canada Life first reported a position in XPeng in Q3 2020 and held it in 11 quarters.
  • Canada Life's XPeng position peaked at $22.5M in Q4 2021.
  • 201 funds tracked by Wall St. Rank held XPeng as of Q2 2023.

Based on Canada Life's 13F filing for Q2 2023, filed 10 Aug 2023.